Alvotech’s Japanese Ustekinumab Nod Is ‘First For Global Markets’
Stelara Biosimilar AVT04 To Be Commercialized By Partner Fuji Pharma
Following the formation of their partnership nearly five years ago, Alvotech and Fuji have together welcomed approval in Japan for Alvotech’s biosimilar to Stelara (ustekinumab).
